SCHEMBL6175093

SCHEMBL6175093

CCCCOC(=O)Nc1cc(C(C)C2NC(=O)N(c3ccc(SC(F)(F)F)cc3)C2=O)ccn1

nearest known ligand 0.44

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 15/20 0.44
NPC1 O15118 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PDE2A O00408 3/20 0.33
SYK P43405 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6177171 0.92 IGF1R (0.46) IGF1RL3MBTL1PDE2A
SCHEMBL6174445 0.90 IGF1R (0.43) IGF1RPDE2A
SCHEMBL6174018 0.89 SLC5A1 (0.36) IGF1RNPC1HPGDRAB9ASMN1; SMN2
SCHEMBL6172454 0.87 GAA (0.36) IGF1RNPC1HPGDRAB9ASMN1; SMN2
SCHEMBL6177806 0.85 IGF1R (0.43) IGF1RPDE2A
SCHEMBL6173765 0.82 KCNK2 (0.44) IGF1RNPC1RAB9APDE2A
SCHEMBL6172737 0.82 MAPK1 (0.37) L3MBTL1PDE2A
SCHEMBL6174760 0.82 IGF1R (0.41) IGF1RNPC1RAB9APDE2A
SCHEMBL6171505 0.82 IGF1R (0.34) IGF1RNPC1HPGDRAB9ASMN1; SMN2
SCHEMBL6176013 0.81 IGF1R (0.41) IGF1RNPC1RAB9APDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed